Series B funding round for Eliem Therapeutics raising $60M in May 2021
Series B funding round for Eliem Therapeutics raising $60M in May 2021
| Investor | Firm Type | Partner |
|---|
| Private | — |
ICGLEAD | Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Syndicate | — |
| Foundation | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Vasudev Bailey |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$260M
Top Valuation
-
Eliem Therapeutics raised $60M in a Series B round.
The round was announced on 05/01/21.
The round was led by Simon Tate, RA Capital Management.